|
CN111909115A
|
|
Synthesis method of diphenhydrasol hydrochloride
|
|
CN112047999A
|
|
Preparation method of gamma-crystal form arginine perindopril salt
|
|
CN111170922A
|
|
Impurity generated in indapamide production, and synthetic method and application thereof
|
|
CN110483455A
|
|
A kind of synthetic method of sulfuric acid Walla pa sand intermediate aldehydes substratess
|
|
CN110590814A
|
|
Synthetic method of dimer impurity generated in production of cefazolin sodium
|
|
CN110526870A
|
|
A kind of preparation method of eltrombopag olamine
|
|
CN110133169A
|
|
A kind of method and application using frusemide in LC-MS detection human plasma
|
|
CN108578379A
|
|
A kind of preparation method of indapamide slow release tablet
|
|
CN108299335A
|
|
A kind of synthetic method converting impurity 3- formoxyl Febustats to Febustat
|
|
CN107674040A
|
|
A kind of Febustat impurity is converted into the new method of Febustat
|
|
CN106478465A
|
|
A kind of synthetic method of olsalazine sodium important intermediate hydride
|
|
CN104792918A
|
|
Quality detection method for donkey genital in Nanbao capsule
|
|
CN104606167A
|
|
Aspirin enteric pellet capsule and preparation method thereof
|
|
CN104086435A
|
|
Synthetic method of formoterol fumarate important intermediate benzyl ether compound
|
|
CN102603535A
|
|
Synthetic method of formoterol fumarate intermediate bromide
|
|
CN102100678A
|
|
Itraconazole sulfate capsules and method for preparing same
|
|
CN101786964A
|
|
Improved synthetic method of Olsalazine sodium
|
|
CN101732280A
|
|
Oral preparation of novel colonic positioning release medicine
|
